Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation.
In this study, we asked whether the serum acute-phase protein C-reactive protein (CRP) increased in large surfactant aggregates after lung transplantation and analyzed the changes in composition and interfacial adsorption activity of those aggregates. Single left lung transplantation was performed in weight-matched pairs of dogs. A double-lung block from the donor animal was flushed with either modified Euro-Collins solution (EC) (n = 6) or University of Wisconsin solution (UW) (n = 6) at 4 degrees C followed by immersion in cold EC or UW for 22 h. The left donor lung was transplanted. The recipient dog was then reperfused for 4.5 h. Irrespective of the preservation fluid, gas exchanged was impaired in the transplanted lung after 4.5 h of reperfusion. Large surfactant aggregates obtained from this lung showed reduced ability to rapidly adsorb to an air-liquid interface. Phospholipid (PL) content and PL composition of surfactant from lung transplants was similar to that of the control lungs. However, the content of surfactant protein A decreased after reperfusion. In addition, Western blot analyses showed that levels of CRP increased in surfactant from transplanted but not from donor lungs. The addition of human CRP to control surfactant (CRP:PL weight ratio, 0.01:1) caused a decrease of surfactant adsorption. We conclude that the impairment of adsorption facilities of surfactant from transplanted lungs may be correlated with decreased levels of surfactant protein A and increased levels of CRP. The presence of elevated levels of CRP in bronchoalveolar lavage could be a very sensitive marker of lung injury.
Casals
C
C
Department of Biochemistry and Molecular Biology, Faculty of Biology, Complutense University, Madrid, Spain.
Varela
A
A
Ruano
M L
ML
Valiño
F
F
Pérez-Gil
J
J
Torre
N
N
Jorge
E
E
Tendillo
F
F
Castillo-Olivares
J L
JL
D000327:Adsorption; D000818:Animals; D015415:Biomarkers; D015153:Blotting, Western; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry*; D002097:C-Reactive Protein / Q000032:analysis*; D004195:Disease Models, Animal; D004285:Dogs; D006801:Humans; D016040:Lung Transplantation; D011510:Proteolipids / Q000032:analysis*; D011659:Pulmonary Gas Exchange; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants / Q000032:analysis*; D011897:Random Allocation; D015427:Reperfusion Injury / Q000276:immunology; D012680:Sensitivity and Specificity
D015415:Biomarkers; D011510:Proteolipids; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants; D002097:C-Reactive Protein